Machine learning for predicting cognitive deficits using auditory and demographic factors.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2024
Historique:
received: 06 09 2023
accepted: 15 04 2024
medline: 15 5 2024
pubmed: 15 5 2024
entrez: 14 5 2024
Statut: epublish

Résumé

Predicting neurocognitive deficits using complex auditory assessments could change how cognitive dysfunction is identified, and monitored over time. Detecting cognitive impairment in people living with HIV (PLWH) is important for early intervention, especially in low- to middle-income countries where most cases exist. Auditory tests relate to neurocognitive test results, but the incremental predictive capability beyond demographic factors is unknown. Use machine learning to predict neurocognitive deficits, using auditory tests and demographic factors. The Infectious Disease Center in Dar es Salaam, Tanzania. Participants were 939 Tanzanian individuals from Dar es Salaam living with and without HIV who were part of a longitudinal study. Patients who had only one visit, a positive history of ear drainage, concussion, significant noise or chemical exposure, neurological disease, mental illness, or exposure to ototoxic antibiotics (e.g., gentamycin), or chemotherapy were excluded. This provided 478 participants (349 PLWH, 129 HIV-negative). Participant data were randomized to training and test sets for machine learning. The main outcome was whether auditory variables combined with relevant demographic variables could predict neurocognitive dysfunction (defined as a score of <26 on the Kiswahili Montreal Cognitive Assessment) better than demographic factors alone. The performance of predictive machine learning algorithms was primarily evaluated using the area under the receiver operational characteristic curve. Secondary metrics for evaluation included F1 scores, accuracies, and the Youden's indices for the algorithms. The percentage of individuals with cognitive deficits was 36.2% (139 PLWH and 34 HIV-negative). The Gaussian and kernel naïve Bayes classifiers were the most predictive algorithms for neurocognitive impairment. Algorithms trained with auditory variables had average area under the curve values of 0.91 and 0.87, F1 scores (metric for precision and recall) of 0.81 and 0.76, and average accuracies of 86.3% and 81.9% respectively. Algorithms trained without auditory variables as features were statistically worse (p < .001) in both the primary measure of area under the curve (0.82/0.78) and the secondary measure of accuracy (72.3%/74.5%) for the Gaussian and kernel algorithms respectively. Auditory variables improved the prediction of cognitive function. Since auditory tests are easy-to-administer and often naturalistic tasks, they may offer objective measures or predictors of neurocognitive performance suitable for many global settings. Further research and development into using machine learning algorithms for predicting cognitive outcomes should be pursued.

Identifiants

pubmed: 38743715
doi: 10.1371/journal.pone.0302902
pii: PONE-D-23-26242
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0302902

Informations de copyright

Copyright: © 2024 Niemczak et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

NO authors have competing interests.

Auteurs

Christopher E Niemczak (CE)

Geisel School of Medicine at Dartmouth, Space Medicine Innovations Laboratory, Lebanon, NH, United States of America.
Dartmouth Health, Department of Medicine, Division of Hyperbaric Medicine, Lebanon, NH, United States of America.

Basile Montagnese (B)

Geisel School of Medicine at Dartmouth, Space Medicine Innovations Laboratory, Lebanon, NH, United States of America.

Joshua Levy (J)

Dartmouth Health, Department of Pathology and Laboratory Medicine, Lebanon, NH, United States of America.
Dartmouth Health, Department of Dermatology, Lebanon, NH, United States of America.
Geisel School of Medicine at Dartmouth, Epidemiology, Lebanon, NH, United States of America.
Geisel School of Medicine at Dartmouth, Program in Quantitative Biomedical Sciences, Lebanon, NH, United States of America.

Abigail M Fellows (AM)

Dartmouth Health, Department of Medicine, Division of Hyperbaric Medicine, Lebanon, NH, United States of America.

Jiang Gui (J)

Geisel School of Medicine at Dartmouth, Program in Quantitative Biomedical Sciences, Lebanon, NH, United States of America.
Geisel School of Medicine at Dartmouth, Biomedical Data Science, Lebanon, NH, United States of America.

Samantha M Leigh (SM)

Dartmouth Health, Department of Medicine, Division of Hyperbaric Medicine, Lebanon, NH, United States of America.

Albert Magohe (A)

Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.

Enica R Massawe (ER)

Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.

Jay C Buckey (JC)

Geisel School of Medicine at Dartmouth, Space Medicine Innovations Laboratory, Lebanon, NH, United States of America.
Dartmouth Health, Department of Medicine, Division of Hyperbaric Medicine, Lebanon, NH, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH